Nureca Limited has informed the Exchange regarding Appointment of Ms Ruchita Agarwal as Independent Director of the company w.e.f. October 29, 2025 for a period of 5 years .
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited's board, at its May 5, 2025 meeting, approved audited standalone and consolidated financial results for Q4 and FY ending March 31, 2025 with an unmodified auditor opinion. The standalone results reported a net loss for the year, with revenue of Rs. 1,146.40 million and net worth of Rs. 1,917.38 million. B S R & Co. LLP was replaced by M/s Singhi & Co. as statutory auditors for a 5-year term, while new internal and secretarial auditors were also appointed. The board gave in-principle approval to merge wholly owned subsidiary Nureca Technologies Private Limited (FY25 revenue Rs. 228.14 million) into the parent company, with no change in shareholding pattern. Several directors including Ms. Ruchita Agarwal, Ms. Charu Singh, and Mr. Vijay Kumar Sharma were re-appointed as Independent Directors for a second 5-year term, and Mr. Rajinder Sharma was re-appointed as Whole-time Director. The 9th AGM is set for June 16, 2025.
Routine governance housekeeping for shareholders. The auditor rotation is standard (term completion, not a mid-term exit), and the subsidiary merger simplifies the group structure with no share issuance or dilution. The reported net loss in standalone results is a point worth monitoring, but the clean audit opinion provides some comfort.